Postdoctoral positions are available immediately in the Cardiovascular Research Laboratory at Huntington Medical Research Institutes (HMRI), Pasadena, CA to investigate new mechanisms and models in heart failure and cardiogenic shock and generate novel approaches to reduce cell death during heart attack. New pharmacologic therapies that protect the mitochondria during ischemia/reperfusion are a recent focus of the laboratory. In addition, the acute and chronic effects of the now popular electronic cigarette smoke or vaping on the cardiovascular system in normal young versus old hearts, as well as hearts with underlying heart disease will be carefully examined. Furthermore, the effect of pure nicotine on the heart will be studied.
Candidates with a background in vascular and myocardial biology will be preferred. Experience in molecular and cell biology techniques, biochemistry, bioinformatics, and murine cardiac models are all considered strengths for this position. Candidates, with a recent PhD degree, and a good track record of publications, will be given priority. The initial appointment will be for two years with the possibility of extension. Salary will be commensurate with qualifications, laboratory experience, and institutional guidelines.
Robert Kloner, MD, PhD
Chief Science Officer and Scientific Director, Cardiovascular Research Program
Huntington Medical Research Institutes (HMRI)